Ligand validation:6AZS

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AZS_BTB_A_301	74%	74%	0.109	0.94	0.55	0.47	-	-	3	0	100%	1
6AZS_BTB_B_301	72%	52%	0.106	0.93	0.77	1.08	-	1	2	0	100%	1
6AZS_BTB_D_301	69%	59%	0.106	0.919	0.69	0.89	-	-	7	0	100%	1
6AZS_BTB_C_301	61%	62%	0.121	0.908	0.74	0.71	-	-	9	0	100%	1
5BK6_BTB_D_301	71%	34%	0.095	0.916	1.38	1.25	2	-	0	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9Q4X_BTB_A_504	100%	62%	0.027	0.995	0.56	0.88	-	-	6	0	100%	1
9Q58_BTB_A_504	100%	66%	0.029	0.995	0.43	0.88	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.